X
MIRM icon

Xponance’s Mirum Pharmaceuticals MIRM Stock Holding History

Xponance’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$422K Buy
4,569
+1,363
+43% +$128K ﹤0.01% 1079
2025
Q4 		$253K Buy
3,206
+55
+2% +$3.95K ﹤0.01% 1266
2025
Q3 		$231K Buy
+3,151
New +$200K ﹤0.01% 1286

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Xponance's MIRM Position: Q1 2026 in Review

Xponance increased its Mirum Pharmaceuticals (MIRM) stake by 43% in Q1 2026, buying an estimated $128K and bringing the position to 4,569 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #1079.

Xponance first reported a position in MIRM in Q3 2025 and has held it in 3 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Xponance held 4,569 shares of Mirum Pharmaceuticals worth $422K as of Q1 2026.
  • Xponance bought 1,363 Mirum Pharmaceuticals shares in Q1 2026, an estimated $128K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1079 holding.
  • Xponance first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.